1143 Treatment of patients with metastatic papillary-type II and clear-cell renal cell carcinoma – comparison of the survival with tyrosine kinase inhibitors

DOI: 10.1016/s1569-9056(14)61123-4 Publication Date: 2014-04-24T10:35:25Z